(Q43539794)

English

Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia

scientific article published in January 2001

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

0 references

author name string

Herken H

1

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Uz E

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Ozyurt H

3

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Söğüt S

4

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Virit O

5

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Akyol O

6

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

language of work or name

0 references

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Molecular Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

66-73

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Superoxide Radical: An Endogenous Toxicant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000789

21 January 2018

Free radical pathology and antioxidant defense in schizophrenia: a review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000789

21 January 2018

Effects of haloperidol on antioxidant defense system enzymes in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000789

21 January 2018

Impaired antioxidant defense at the onset of psychosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000789

21 January 2018

Glutathione peroxidase and CT scan abnormalities in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000789

21 January 2018

Superoxide, neuroleptics and the ubiquinone and cytochrome b5 reductases in brain and lymphocytes from normals and schizophrenic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000789

21 January 2018

Oxygen free radicals and brain dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000789

21 January 2018

Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000789

21 January 2018

Tardive dyskinesia: possible involvement of free radicals and treatment with vitamin E.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000789

21 January 2018

Erythrocyte membrane phospholipids in psychotic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000789

21 January 2018

Fatty acid levels in the brains of schizophrenics and normal controls

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000789

21 January 2018

Red blood cell membrane dynamics in schizophrenia. II. Fatty acid composition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000789

21 January 2018

Abnormal incorporation of arachidonic acid into platelets of drug-free patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000789

21 January 2018

Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000789

21 January 2018

MRI evidence that docosahexaenoic acid ethyl ester improves myelination in generalized peroxisomal disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000789

21 January 2018

Increased platelet phospholipase A2 activity in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000789

21 January 2018

Increased content of immunoreactive prostaglandin E in cerebrospinal fluid of patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000789

21 January 2018

Oxidative injury and potential use of antioxidants in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000789

21 January 2018

Free radicals in brain metabolism and pathology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000789

21 January 2018

The preventative role of antioxidants (selegiline and vitamin E) in a rat model of tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000789

21 January 2018

CSF Prostaglandin Levels in Depressed and Schizophrenic Patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000789

21 January 2018

Cytotoxicity and genotoxicity of lipid-oxidation products

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000789

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative proteome analysis of the hippocampus implicates chromosome 6q in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000789

7 January 2021

based on heuristic

inferred from DOI database lookup

Low superoxide dismutase activity in schizophrenic patients with tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000789

7 January 2021

based on heuristic

inferred from DOI database lookup

A methodological approach to superoxide dismutase (SOD) activity assay based on inhibition of nitroblue tetrazolium (NBT) reduction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000789

7 January 2021

based on heuristic

inferred from DOI database lookup

Enzymes of the antioxidant defense system in chronic schizophrenic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000789

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelet glutathione peroxidase and monoamine oxidase activity in schizophrenics with CT scan abnormalities: relation to psychosocial variables

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000789

7 January 2021

based on heuristic

inferred from DOI database lookup

Human plasma glutathione peroxidase and symptom severity in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000789

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of vitamin E addition to acute neuroleptic treatment on the emergence of extrapyramidal side effects in schizophrenic patients: an open label study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000789

7 January 2021

based on heuristic

inferred from DOI database lookup

High doses of vitamin E in the treatment of disorders of the central nervous system in the aged

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000789

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased turnover of platelet phosphatidylinositol in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000789

7 January 2021

based on heuristic

inferred from DOI database lookup

Red blood cell membrane dynamics in schizophrenia. I. Membrane fluidity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000789

7 January 2021

based on heuristic

inferred from DOI database lookup

Incorporation of 3H-arachidonic acid into platelet phospholipids of patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000789

7 January 2021

based on heuristic

inferred from DOI database lookup

Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000789

7 January 2021

based on heuristic

inferred from DOI database lookup

Fatty acids, cytokines, and major depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000789

7 January 2021

based on heuristic

inferred from DOI database lookup

Essential fatty acids and abnormal involuntary movements in the general male population: a study of men born in 1933

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000789

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased plasma phospholipase-A2 activity in schizophrenic patients: reduction after neuroleptic therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000789

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated plasma prostaglandin E2 levels in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000789

7 January 2021

based on heuristic

inferred from DOI database lookup

An adjunctive role for ascorbic acid in the treatment of schizophrenia?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000789

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.MP.4000789

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43539794&oldid=2206111870"